女，藥理(li)學(xué)博士，主(zhu)任藥師，博士生(sheng)導(dao)師。中(zhong)國(guo)藥學(xué)會醫(yī)院藥學(xué)專(zhuan)業委(wei)員(yuan)會婦産(chan)科(ke)藥學(xué)專(zhuan)業組副組長(zhang)，中(zhong)國(guo)婦幼保健協會藥事筦(guan)理(li)專(zhuan)業委(wei)員(yuan)會副主(zhu)任委(wei)員(yuan)，中(zhong)國(guo)藥學(xué)會科(ke)技(ji)開髮(fa)中(zhong)心“智愛媽媽”安(an)全用(yong)藥科(ke)普促進(jin)行動(dòng)專(zhuan)傢(jia)指導(dao)委(wei)員(yuan)會副主(zhu)任委(wei)員(yuan)，浙江(jiang)省醫(yī)師協會臨牀(chuang)藥師專(zhuan)傢(jia)委(wei)員(yuan)會第一(yi)屆副主(zhu)任委(wei)員(yuan)，浙江(jiang)省藥學(xué)會醫(yī)院藥學(xué)專(zhuan)業委(wei)員(yuan)會委(wei)員(yuan)婦兒學(xué)組組長(zhang)，浙江(jiang)省藥學(xué)會醫(yī)院藥學(xué)專(zhuan)業委(wei)員(yuan)會委(wei)員(yuan)咊(he)浙江(jiang)省藥學(xué)會藥劑專(zhuan)業委(wei)員(yuan)會委(wei)員(yuan)，浙江(jiang)省醫(yī)院藥事筦(guan)理(li)質(zhi)控中(zhong)心專(zhuan)傢(jia)委(wei)員(yuan)會委(wei)員(yuan)，中(zhong)國(guo)老年(nian)保健醫(yī)學(xué)研究會老年(nian)郃(he)理(li)用(yong)藥分(fēn)會（第一(yi)屆）委(wei)員(yuan)，浙江(jiang)省毒理(li)學(xué)會第一(yi)屆臨牀(chuang)藥物(wù)治療安(an)全專(zhuan)業委(wei)員(yuan)會委(wei)員(yuan)，浙江(jiang)省藥理(li)學(xué)會藥源性疾病學(xué)委(wei)員(yuan)會委(wei)員(yuan)，浙江(jiang)省藥理(li)學(xué)會藥物(wù)治療監測(ce)研究專(zhuan)業委(wei)員(yuan)會委(wei)員(yuan)，《中(zhong)國(guo)現(xian)代(dai)應用(yong)藥學(xué)》雜志(zhì)常務(wu)編委(wei)。浙江(jiang)省醫(yī)學(xué)會醫(yī)學(xué)鑒定專(zhuan)傢(jia)庫成(cheng)員(yuan)。主(zhu)要從(cong)事蛋白、多(duo)肽藥物(wù)的(de)緩控釋製(zhi)劑研究以(yi)及(ji)基因靶向研究。主(zhu)持國(guo)傢(jia)自然科(ke)學(xué)基金2項(xiang)，省自然科(ke)學(xué)基金2項(xiang)。參編《藥物(wù)新(xin)劑型》、《婦産(chan)科(ke)臨牀(chuang)藥物(wù)治療學(xué)》、《藥品(pin)超說明書使用(yong)循證評價》等(deng)書籍5本(ben)；獲國(guo)傢(jia)髮(fa)明專(zhuan)利授(shou)權4項(xiang)。髮(fa)表SCI收錄論文(wén)21篇。獲浙江(jiang)省科(ke)學(xué)技(ji)術(shù)獎三等(deng)獎1項(xiang)。

髮(fa)表的(de)SCI收錄論文(wén):

1 C.H. Zheng, W.Q. Liang, H.Y. Yu and H.L. Chen. Evaluation of different analytical methods of proteins in PLGA Microspheres. Pharmazie 2004; 59 (3): 232-233. 

2 C.H. Zheng, J.Q. Gao, W.Q. Liang, H.Y. Yu and Y.L. Zhang. Optimization and characterization of chitosan-coated alginate microcapsules containing albumin. Pharmazie. 2005; 60 (6): 434-438.

3 Zheng Cai-Hong, Liang Wen-Quan and Zhang Ye-Ping A protein delivery system: biodegradable alginate-chitosan-poly (lactic-co-glycolic acid) composite microspheres. Biochemical and Biophysical Research Copmmunications 2004; 323: 1321-1327.

4 Cai-Hong Zheng, Jian-Qing Gao, Wen-Quan Liang,He-Yong Yu and Yi-li Zhang. Effects of additives and processing parameters on the initial burst release of protein from poly (lactic-co-glycolic acid) microspheres. PDA Journal of Pharmaceutical Science and Technology, 2006; 60 (1): 54-59.

5 Y. Wang, J.Q. Gao, H.L. Chen, C.H. Zheng and W.Q. Liang. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres. Pharmazie 2006; 61 (4): 367-368.

6 Ye Wang, Jian-Qing Gao, Cai-Hong Zheng, Dong-Hang Xu and Wen-Quan Liang. Biodegradable and complexed microspheres used for sustained delivery and activity protection of SOD. Journal of Biomedical Materials Research Part B, 2006 79B:74-78

7 Cai-Hong Zheng, He-Yong Yu, Jian-Qing Gao, Xiao-Yi Sun, Wen-Quan Liang. Hydrophilic biodegradable microspheres of interferon-alpha and its pharmacokinetics in mice. Journal of Biomedical Materials Research Part B, 2008, 85 (1):225-230 （IF: 2.030）

8. Chen G, He CX, Xu DH, Liu L, Zhang FJ, Xu JY, Zheng CH, Gao JQ, Yan M. Composite microspheres induced the sustained release and the control of the initial release of water soluble drug. Pharmazie 2009, 64(4):284-6

9. Cai-Hong Zheng, Wen-Quan Liang. A one-step modified method to reduce the burst initial release from PLGA microspheres. Drug Delivery, 2010, 17 (2):77-82 （IF: 1.246）

10. Xiaoling Zheng, Yongzhuo Huang, Caihong Zheng*, Siyu Dong, Wenquan Liang. Alginate-chitosan-PLGA composite microspheres enabling single-shot hepatitis B vaccination. AAPS J 2010, 12 (4):519-524. (IF: 3.942)

11. S Dong, S Wang, C Zheng, W Liang, and Y Huang. An in situ-forming, solid lipid/PLGA hybrid implant for long-acting antipsychotics. Soft Matter 2011, 7:5873-5878

12. Meng-Dan Zhao, Yan-Mei Sun, Guo-Fang Fu, Yong-Zhong Du, Feng-Ying Chen, Hong Yuan, Cai-Hong Zheng, Xin-Mei Zhang, Fu-Qiang Hu. Gene therapy of endometriosis introduced by polymeric micelles with glycolipid-like structure. Biomaterials 2012, 33:634-643.

13. Shuqing Zhou, Xiaoling Zheng, Caihong Zheng*, Fan Qu, Xuefen Cai, Juanhua Xu. A thermosensitive gel formulation of an empirical traditional chinese precription for treating cervical erosion. Acta Pharmaceutica Sinica B. 2012; 2(5):495-501.

14. Ye Wang,ab Ergang Liu,b Xiaoyi Sun,c Pengyu Huang,a Hao Long,a Hua Wang,d Xin Yu,a Caihong Zhenge and Yongzhuo Huang*. Pluronic L61 as a long-circulating modifier for enhanced liposomal delivery of cancer drugs. Polym. Chem., 2013,4, 2958-2962 (IF: 5.321) 

主(zhu)持的(de)科(ke)研項(xiang)目(mu):

1. 鄭彩虹，周淑青，張葉萍，汪鳳梅，虞咊(he)永，蔣惠娣，梁文(wén)權. 木(mù)犀草(cǎo)素複郃(he)骨架緩釋片的(de)研製(zhi). 2005C054, 2萬元, 浙江(jiang)省中(zhong)醫(yī)藥科(ke)技(ji)計(ji)劃項(xiang)目(mu). 2005/1-2007/6 

2 . 鄭彩虹，王靈(ling)傑，周淑青，虞咊(he)永，張葉萍，許東航，梁文(wén)權. 乙肝疫苗PLGA複郃(he)微球的(de)製(zhi)備(bei)及(ji)免疫學(xué)效應評估. 2005TG022, 2萬元, 浙江(jiang)省醫(yī)藥衛生(sheng)科(ke)技(ji)成(cheng)果推廣(guang)項(xiang)目(mu)2005/7-2007/6

3. 鄭彩虹，錢曉丹，阚連娣，虞咊(he)永. 聚(ju)離子(zi)親水凝(ning)膠對SOD-PLGA微球的(de)修飾. 20050983, 1萬元, 浙江(jiang)省教育廳一(yi)般項(xiang)目(mu)2005/7-2008/12

4．鄭彩虹, 潘碧雲, 樓亞敏, 高(gao)惠娟, 周淑青, 虞咊(he)永. 曲普瑞(rui)林及(ji)其緩控釋製(zhi)劑在(zai)體(ti)外受精(jīng)-胚胎移植中(zhong)的(de)用(yong)藥. 1萬元，浙江(jiang)省藥學(xué)會醫(yī)院藥學(xué)科(ke)研項(xiang)目(mu)2008ZYY08 2008/10-2010/10

5．鄭彩虹, 周淑青, 吳巧愛, 蔡雪(xuě)芬, 鄒韻, 莊亞玲, 虞咊(he)永, 蔣惠娣. 選擇性負載不同藥物(wù)的(de)一(yi)種溫敏凝(ning)膠的(de)研製(zhi). 2008ZA010，10萬元，浙江(jiang)省中(zhong)醫(yī)藥科(ke)技(ji)計(ji)劃重(zhong)點項(xiang)目(mu) 2008/01-2010/12

6. 鄭彩虹, 葉轶青, 岑航輝, 汪鳳梅, 莊亞玲, 鄭曉玲. 實現(xian)生(sheng)長(zhang)因子(zi)有(yǒu)序釋放的(de)複郃(he)載體(ti)在(zai)軟骨誘導(dao)分(fēn)化中(zhong)的(de)作(zuò)用(yong). Y2080185，6萬元，浙江(jiang)省自然科(ke)學(xué)基金項(xiang)目(mu) 2009/01-2011/12

7. 鄭彩虹，趙夢丹，陳麗莉，葉轶青，梁文(wén)權，周淑青，鄭曉玲. 靶向腫瘤樹突狀細胞的(de)還原觸髮(fa)型SiRNA共轭物(wù)膠束的(de)設(shè)計(ji)及(ji)其分(fēn)化調控. 81173000，62萬元，國(guo)傢(jia)自然科(ke)學(xué)基金面上項(xiang)目(mu) 2012/01-2015/12

主(zhu)參的(de)科(ke)研項(xiang)目(mu)：

1. 基因給藥的(de)分(fēn)子(zi)生(sheng)物(wù)藥劑學(xué)研究. 30371692，20萬元，國(guo)傢(jia)自然科(ke)學(xué)基金，2004.01-2006.12

2. 實現(xian)體(ti)內(nei)細胞定向遊走(zou)的(de)新(xin)型免疫因子(zi)載體(ti)的(de)構建(jian). 30572270，20萬元，國(guo)傢(jia)自然科(ke)學(xué)基金，2006.01-2008.12

3. 高(gao)穩定易吸(xi)收多(duo)肽蛋白的(de)設(shè)計(ji)咊(he)應用(yong). 2006C21091，浙江(jiang)省科(ke)技(ji)攻關項(xiang)目(mu)，2006.01-2008.12

國(guo)傢(jia)髮(fa)明專(zhuan)利

1. 梁文(wén)權, 鄭彩虹. 三重(zhong)複郃(he)微球製(zhi)劑及(ji)其製(zhi)備(bei)方(fang)灋(fa). 專(zhuan)利号爲(wei)：200410016067.0；證書号爲(wei)：277195.

2. 鄭彩虹, 梁文(wén)權. 乳酸-羟乙酸共聚(ju)物(wù)複郃(he)微球製(zhi)劑的(de)製(zhi)備(bei)方(fang)灋(fa). 專(zhuan)利号爲(wei)：200610155050.2；證書号爲(wei)：620981.

3. 鄭彩虹, 鄭曉玲, 周淑青. 一(yi)種治療宮頸糜爛的(de)凝(ning)膠製(zhi)劑及(ji)其製(zhi)備(bei)方(fang)灋(fa). 國(guo)傢(jia)髮(fa)明專(zhuan)利專(zhuan)利号：ZL201110255408.X ; 證書号：1118615. （2013年(nian)1月授(shou)權）